VERICEL CORP (VCEL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for VCEL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| VCEL | Chairperson of the Invivyd board’s audit committee and compensation committee | 69 | ["Audit committee financial expert","Oversight of financial statements","Experience with independent accountants","more than 40 years of operating management and financial experience spanning the biotech, high-tech and education industries","served for 11 years as the Senior Vice President, Chief Financial Officer and Treasurer of Acceleron Pharma Inc.","former member of the board of directors of Decibel Therapeutics","Co-founder, Chief Operating Officer and a director of Aptius Education, Inc."] | ["Audit Committee","compensation committee"] | 2026 |
Biography sourced from the proxy statement filing.
Kevin McLaughlin, 68 Independent Former Chief Financial Officer and Treasurer, Acceleron Pharma Inc. Director Since: 2015 Other Current Public Company Directorships: Vericel Board committee(s): Invivyd, Inc. Audit (Chair) Committee Key Experience and Qualifications BioPharma: Mr. McLaughlin has more than 40 years of operating management and financial experience spanning the biotech, high-tech and education industries. Finance: Mr. McLaughlin served for 11 years as the Senior Vice President, Chief Financial Officer and Treasurer of Acceleron, Pharma Inc., until its acquisition by Merck & Co. in 2021. Prior to Acceleron, he served as Senior Vice President and Chief Financial Officer of Qteros, Inc., a cellulosic biofuels company. Professional Highlights Senior Vice President, Chief Financial Officer and Treasurer of Acceleron Pharma Inc., a publicly-traded biopharmaceutical company (2010-2021) Senior Vice President and Chief Financial Officer of Qteros, Inc., a cellulosic biofuels company (2009-2010) Co-founder, Chief Operating Officer and a director of Aptius Education, Inc., a publishing company (2007-2009) President and Chief Executive Officer and a member of the board of directors of PRAECIS Pharmaceuticals until its sale to GSK plc (formerly GlaxoSmithKline). Mr. McLaughlin joined PRAECIS as its first Chief Financial Officer and also served as Chief Operating Officer. Other Leadership Positions and Experiences Former member of the board of directors of Decibel Therapeutics, a clinical-stage and public biotechnology company dedicated to discovering treatments to restore and improve hearing and balance, which was acquired by Regeneron Pharmaceuticals in 2023 Member of the board of directors of Invivyd, Inc., a public biopharmaceutical company dedicated to delivering protection from serious viral infectious diseases. Mr. McLaughlin serves as the Chairperson of the Invivyd board s audit committee. Education B.S. in business from Northeastern University and an M.B.A. from the F.W. Olin Graduate School of Business at Babson College